Cargando…

Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy

BACKGROUND: Idiopathic membranous nephropathy (IMN) is one of the most common adult nephrotic syndromes. Some patients with this disorder require immunosuppressive therapy. This retrospective case series was performed to assess the effects of tacrolimus (TAC) combined with Tripterygium wilfordii pol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shang, Shun-Lai, Cai, Guang-Yan, Duan, Shu-wei, Li, Ping, Li, Qing-Gang, Chen, Xiang-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052665/ https://www.ncbi.nlm.nih.gov/pubmed/30021637 http://dx.doi.org/10.1186/s12882-018-0967-5

Ejemplares similares

Calcineurin inhibitor therapy in combination with Tripterygium wilfordii polyglycoside tablets for idiopathic membranous nephropathy: A retrospective clinical observation
por: Gao, Ying, et al.
Publicado: (2021)

Effect of Tripterygium Wilfordii Polyglycoside on Experimental Prostatitis Caused by Ureaplasma Urealyticum in Rats
por: Shan, Pingnan, et al.
Publicado: (2016)

Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study
por: Liu, Shanshan, et al.
Publicado: (2015)

Retrospective analysis of Tripterygium wilfordii polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with sub-nephrotic proteinuria
por: Guo, Yuanyuan, et al.
Publicado: (2021)

Meta-Analysis of Clinical Efficacy and Safety of Tripterygium wilfordii Polyglycosides Tablets in the Treatment of Chronic Kidney Disease
por: Guo, Yan-Li, et al.
Publicado: (2021)

Efficacy and safety of Tripterygium wilfordii polyglycosides for diabetic kidney disease: an overview of systematic reviews and meta-analyses
por: Wang, Ying, et al.
Publicado: (2022)

Mechanism of action of Tripterygium wilfordii for treatment of idiopathic membranous nephropathy based on network pharmacology
por: Shi, Honghong, et al.
Publicado: (2022)

Tripterygium wilfordii Polyglycoside Ameliorated TNBS-Induced Colitis in Rats via Regulating Th17/Treg Balance in Intestinal Mucosa
por: Zhang, Cui, et al.
Publicado: (2021)

Efficacy and safety of tripterygium wilfordii multiglycosides in idiopathic membranous nephropathy: Protocol for an open-label randomized controlled clinical trial
por: Geng, Chanyu, et al.
Publicado: (2022)

Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis
por: Wang, Hongyun, et al.
Publicado: (2023)

Effect of Cordyceps sinensis and Tripterygium wilfordii polyglycosidium on podocytes in rats with diabetic nephropathy
por: HAO, LI, et al.
Publicado: (2014)

Guilu-Erxian-Glue alleviates Tripterygium wilfordii polyglycoside-induced oligoasthenospermia in rats by resisting ferroptosis via the Keap1/Nrf2/GPX4 signaling pathway
por: Ding, Jin, et al.
Publicado: (2023)

Tripterygium wilfordii multiglycosides combined with prednisone in the treatment of idiopathic membranous nephropathy: A protocol for a systematic review and meta-analysis
por: Jin, Yuxia, et al.
Publicado: (2020)

Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy
por: Wang, Lin, et al.
Publicado: (2021)

Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
por: Lin, Na, et al.
Publicado: (2021)

Mechanistic analysis for the origin of diverse diterpenes in Tripterygium wilfordii
por: Tu, Lichan, et al.
Publicado: (2022)

The genome of Tripterygium wilfordii and characterization of the celastrol biosynthesis pathway
por: Pei, Tianlin, et al.
Publicado: (2021)

Based on Network Pharmacology Tools to Investigate the Mechanism of Tripterygium wilfordii Against IgA Nephropathy
por: Xia, Ming, et al.
Publicado: (2021)

The effect and safety of low-dose Tripterygium wilfordii in patients with type 2 diabetic nephropathy: A meta-analysis
por: Chen, Yixuan, et al.
Publicado: (2022)

Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial
por: Ge, Yongchun, et al.
Publicado: (2013)

Secondary Metabolites and Biological Activities of Talaromyces sp. LGT-2, an Endophytic Fungus from Tripterygium Wilfordii
por: Zhao, Qiu-Hong, et al.
Publicado: (2016)

Therapeutic effect of Tripterygium wilfordii Hook F multiglycosides on gut barrier dysfunction in rats with acute necrotizing pancreatitis
por: WANG, JIE, et al.
Publicado: (2013)

Investigating the Catalytic Activity of Glycosyltransferase on Quercetin from Tripterygium wilfordii
por: Gao, Jie, et al.
Publicado: (2020)

The complete chloroplast genome of Tripterygium wilfordii Hook. f. (Celastraceae)
por: Zhong, Yuan, et al.
Publicado: (2022)

New 18(4→3)-Abeo-Abietanoids from Tripterygium wilfordii
por: Ni, Lin, et al.
Publicado: (2018)

Molecular mechanism of reproductive toxicity induced by Tripterygium Wilfordii based on network pharmacology
por: Ding, Qing, et al.
Publicado: (2021)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordii
por: Ji, Wei, et al.
Publicado: (2010)

The Active Compounds and Therapeutic Target of Tripterygium wilfordii Hook. f. in Attenuating Proteinuria in Diabetic Nephropathy: A Review
por: Liu, Peng, et al.
Publicado: (2021)

Native Endophytes of Tripterygium wilfordii-Mediated Biotransformation Reduces Toxicity of Celastrol
por: Ma, Ping-yang, et al.
Publicado: (2022)

Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy
por: Cui, W., et al.
Publicado: (2017)

Molecular Cloning and Characterisation of Farnesyl Pyrophosphate Synthase from Tripterygium wilfordii
por: Zhao, Yu-Jun, et al.
Publicado: (2015)

Immunosuppressive Sesquiterpene Pyridine Alkaloids from Tripterygium wilfordii Hook. f.
por: Wang, Yadan, et al.
Publicado: (2022)

Tripterygium wilfordii Hook. f. Preparations for Rheumatoid Arthritis: An Overview of Systematic Reviews
por: Li, Huimin, et al.
Publicado: (2022)

Screening of major hepatotoxic components of Tripterygium wilfordii based on hepatotoxic injury patterns
por: Li, Meng, et al.
Publicado: (2023)

Tripterygium wilfordii Hook F Treatment for Stage IV Diabetic Nephropathy: Protocol for a Prospective, Randomized Controlled Trial
por: Lengnan, Xu, et al.
Publicado: (2020)

Bibliometric analysis of trends in research of Tripterygium wilfordii Hook F for treating rheumatoid arthritis
por: Li, Wenyuan, et al.
Publicado: (2023)

Tripterygium wilfordii derivative LLDT-8 targets CD2 in the treatment of rheumatoid arthritis
por: Li, Yuan, et al.
Publicado: (2021)

Genome of Tripterygium wilfordii and identification of cytochrome P450 involved in triptolide biosynthesis
por: Tu, Lichan, et al.
Publicado: (2020)

Applications and Mechanisms of Tripterygium Wilfordii Hook. F. and its Preparations in Kidney Diseases
por: Tong, Xue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ajdu5lgbdu4uojjqgo4eg1sbv2